129 related articles for article (PubMed ID: 18414356)
1. PET imaging in endocrine tumours.
Khan S; Lloyd C; Szyszko T; Win Z; Rubello D; Al-Nahhas A
Minerva Endocrinol; 2008 Jun; 33(2):41-52. PubMed ID: 18414356
[TBL] [Abstract][Full Text] [Related]
2. Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.
Naji M; Hodolic M; El-Refai S; Khan S; Marzola MC; Rubello D; Al-Nahhas A
J Endocrinol Invest; 2010 Jan; 33(1):54-60. PubMed ID: 19820296
[TBL] [Abstract][Full Text] [Related]
3. Developments in PET for the detection of endocrine tumours.
Eriksson B; Orlefors H; Oberg K; Sundin A; Bergström M; Långström B
Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):311-24. PubMed ID: 15763703
[TBL] [Abstract][Full Text] [Related]
4. Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors.
Panagiotidis E; Bomanji J
PET Clin; 2014 Jan; 9(1):43-55. PubMed ID: 25029933
[TBL] [Abstract][Full Text] [Related]
5. Clinical indications for Gallium-68 positron emission tomography imaging.
Khan MU; Khan S; El-Refaie S; Win Z; Rubello D; Al-Nahhas A
Eur J Surg Oncol; 2009 Jun; 35(6):561-7. PubMed ID: 19201567
[TBL] [Abstract][Full Text] [Related]
6. PET and PET/CT in endocrine tumours.
Dudczak R; Traub-Weidinger T
Eur J Radiol; 2010 Mar; 73(3):481-93. PubMed ID: 20089377
[TBL] [Abstract][Full Text] [Related]
7. Clinical role of positron emission tomography (PET) in endocrine tumours.
Rubello D; Rufini V; Casara D; Calcagni ML; Samanes Gajate AM; Shapiro B
Panminerva Med; 2002 Sep; 44(3):185-96. PubMed ID: 12094132
[TBL] [Abstract][Full Text] [Related]
8. Contemporary nuclear medicine imaging of neuroendocrine tumours.
Wong KK; Waterfield RT; Marzola MC; Scarsbrook AF; Chowdhury FU; Gross MD; Rubello D
Clin Radiol; 2012 Nov; 67(11):1035-50. PubMed ID: 22633086
[TBL] [Abstract][Full Text] [Related]
9. Role of positron emission tomography in thyroid and neuroendocrine tumors.
Treglia G; Kroiss AS; Piccardo A; Lococo F; Santhanam P; Imperiale A
Minerva Endocrinol; 2018 Sep; 43(3):341-355. PubMed ID: 28949122
[TBL] [Abstract][Full Text] [Related]
10. Analysis of adrenal masses by 18F-FDG positron emission tomography scanning.
Han SJ; Kim TS; Jeon SW; Jeong SJ; Yun M; Rhee Y; Kang ES; Cha BS; Lee EJ; Lee HC; Lim SK
Int J Clin Pract; 2007 May; 61(5):802-9. PubMed ID: 17343665
[TBL] [Abstract][Full Text] [Related]
11. The role of positron emission tomography (PET) in diagnostics of gastroenteropancreatic neuroendocrine tumours (GEP NET).
Junik R; Drobik P; Małkowski B; Kobus-Błachnio K
Adv Med Sci; 2006; 51():66-8. PubMed ID: 17357280
[TBL] [Abstract][Full Text] [Related]
12. Imaging of neuroendocrine tumors.
Rufini V; Calcagni ML; Baum RP
Semin Nucl Med; 2006 Jul; 36(3):228-47. PubMed ID: 16762613
[TBL] [Abstract][Full Text] [Related]
13. Novel PET tracers: added value for endocrine disorders.
Bergeret S; Charbit J; Ansquer C; Bera G; Chanson P; Lussey-Lepoutre C
Endocrine; 2019 Apr; 64(1):14-30. PubMed ID: 30875057
[TBL] [Abstract][Full Text] [Related]
14. Role of Fluorodeoxyglucose PET/Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies.
Pattison DA; Hofman MS
PET Clin; 2015 Oct; 10(4):461-76. PubMed ID: 26384593
[TBL] [Abstract][Full Text] [Related]
15. Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP).
Ambrosini V; Morigi JJ; Nanni C; Castellucci P; Fanti S
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):58-69. PubMed ID: 25677589
[TBL] [Abstract][Full Text] [Related]
16. [Radioisotopic imaging of neuroendocrine tumours. Which radiopharmaceutical and which diagnostic procedure?].
Bombardieri E; Maccauro M; Castellani MR; Chiti A; Procopio G; Bajetta E; Seregni E
Minerva Endocrinol; 2001 Dec; 26(4):197-213. PubMed ID: 11782705
[TBL] [Abstract][Full Text] [Related]
17. Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging?
Pagou M; Zerizer I; Al-Nahhas A
Hell J Nucl Med; 2009; 12(2):102-5. PubMed ID: 19675859
[TBL] [Abstract][Full Text] [Related]
18. Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.
Bombardieri E; Seregni E; Villano C; Chiti A; Bajetta E
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):150-63. PubMed ID: 15243410
[TBL] [Abstract][Full Text] [Related]
19. Functional imaging of endocrine tumors: role of positron emission tomography.
Pacak K; Eisenhofer G; Goldstein DS
Endocr Rev; 2004 Aug; 25(4):568-80. PubMed ID: 15294882
[TBL] [Abstract][Full Text] [Related]
20. Nuclear imaging of neuroendocrine tumours.
Sundin A; Garske U; Orlefors H
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):69-85. PubMed ID: 17382266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
